SCHEMBL3720121

SCHEMBL3720121

CN(C)c1nc(C(N)=O)cc(-c2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.55

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 14/20 0.55
KDM4E B2RXH2 1/20 0.51
CASP1 P29466 1/20 0.46
ADORA3 P0DMS8 1/20 0.45
FPR2 P25090 2/20 0.43
KMT2A Q03164 1/20 0.42
PARP1 P09874 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1734231 0.86 KDM4E (0.71) SCN9AKDM4ECASP1ADORA3FPR2
SCHEMBL3724770 0.86 SCN9A (0.50) SCN9AKDM4ECASP1ADORA3
SCHEMBL3727410 0.82 SCN9A (0.53) SCN9ACASP1ADORA3FPR2KMT2A
SCHEMBL1734250 0.82 KDM4E (0.72) SCN9AKDM4ECASP1ADORA3KMT2A
SCHEMBL3725418 0.82 SCN9A (0.57) SCN9ACASP1ADORA3FPR2KMT2A
SCHEMBL3717917 0.81 SCN9A (0.53) SCN9ACASP1ADORA3FPR2KMT2A
SCHEMBL3724727 0.81 SCN9A (0.53) SCN9AKDM4ECASP1ADORA3FPR2
SCHEMBL1734266 0.80 KDM4E (0.58) SCN9AKDM4ECASP1ADORA3FPR2
SCHEMBL3724700 0.80 SCN9A (0.51) SCN9ACASP1ADORA3FPR2KMT2A
SCHEMBL3721093 0.79 SCN9A (0.53) SCN9AKDM4ECASP1ADORA3FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 US claimed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO claimed
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 US disclosed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO disclosed